About ACE

Our story

Founded in 2021 by Director Professor Jose Polo, The Adelaide Centre for Epigenetics (ACE) is part of the Faculty of Health and Medical Sciences under the School of Biomedicine, and also has strong ties to the South Australian immunoGENomics Cancer Institute (SAiGENCI). ACE strives to be at the forefront of epigenetics research, with a specific focus on development, cancer and cell fate. Our team includes world renowned researchers, using cutting edge techniques including single cell and spatial omics.

Our mission is not just to understand the complex tapestry of epigenetics in cell fate but to leverage this knowledge in ways that promote health, prevent disease, and illuminate the path for future medical breakthroughs through collaborative and innovative research.

Location

The Adelaide Centre for Epigenetics is located in the University of Adelaide's Adelaide Health and Medical Sciences (AHMS) building (Level 6), a $246 million building housing state-of-the-art facilities for 1600 students and more than 400 researchers. Co-located with the Royal Adelaide Hospital (RAH) and South Australian Health and Medical Research Institute (SAHMRI), the AHMS facility plays a key role in transforming health education, research and patient care.

These facilities at the west end of North Terrace comprise the Adelaide BioMed City precinct, the state's highest priority development for health, research and education infrastructure.